Diabetic Retinopathy Clinical Trials

Diabetic retinopathy clinical trials generally look for adults with diabetes, since the condition develops specifically because of diabetes-related changes to blood vessels in the retina. Some studies focus on people in the earliest stages, before vision changes even appear, while others include those with more advanced retinal damage.

Screening usually involves a review of diabetes history, blood sugar levels, and a dilated eye exam or retinal imaging to confirm the stage of the condition. Some trials may also include people with diabetes who haven't yet developed retinopathy, to study prevention specifically.

What to expect when joining a Diabetic Retinopathy clinical trial?

Joining a diabetic retinopathy clinical trial usually starts with a detailed eye exam, often including retinal imaging, to assess how much the condition has progressed. The research team then walks through informed consent, explaining what the study involves and what risks or benefits participants should know about.

From there, participants might receive an investigational medication, a placebo, or standard care, alongside regular eye exams and blood sugar monitoring to track how both vision and overall diabetes management change over the course of the study.

Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.

Clinical Trial Benefits, Risks & Safety Considerations

Diabetic retinopathy research has grown quickly in recent years, since the condition can be addressed at different points from catching it early through better detection, to slowing damage once it's already present. Because of that, trials in this space generally fall into a few categories.

Injectable medication trials

Injectable medication trials test drugs delivered directly into the eye, often from a drug class known as anti-VEGF injections, to see how well they reduce abnormal blood vessel growth and protect vision. Participants typically include adults with diagnosed diabetic retinopathy at a stage where vision is already affected, and studies track visual acuity and retinal changes through regular eye exams. Many of these studies also include diabetic macular edema (DME), a related complication where fluid builds up in the central part of the retina.

Laser and procedural trials

These trials study laser-based approaches, such as panretinal photocoagulation, sometimes comparing them directly to injectable options to see which one better preserves vision over time. Participants usually include people with more advanced diabetic retinopathy, and research tracks how well the retina responds following the procedure.

Screening and detection trials

These trials focus on improving how diabetic retinopathy is detected in the first place, often testing AI-assisted retinal imaging tools that can flag early changes during a routine diabetes visit. Participants typically include adults with diabetes who haven't necessarily been diagnosed with retinopathy yet, and research measures how accurately and quickly these tools catch cases compared to standard eye exams.

Not usually in a strict sense. Most diabetic retinopathy trials focus on the stage and severity of the eye condition itself rather than whether someone has type 1 or type 2 diabetes, and many studies enroll both. That said, diabetes type can still factor in indirectly, since type 1 diabetes typically needs to be present for a longer period before retinopathy develops, while type 2 diabetes can sometimes go undiagnosed for years, meaning retinopathy may already be present earlier in the disease course.

Some studies are designed specifically around one group, such as research focused on younger people with type 2 diabetes, so it's always worth checking a specific trial's requirements rather than assuming type 1 or type 2 status alone determines eligibility.

Enrolling in a Diabetic Retinopathy clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:

1. Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials focused on diabetic retinopathy and related diabetes-and-eye-health research. This first step simplifies the process of finding studies relevant to your stage of diabetes or the vision changes you've noticed.
2. Select Your Preferred Location: To find diabetic retinopathy clinical trials near you, including those affiliated with eye care or ophthalmology centers, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
3. Explore Study Details: For in-depth information about each study, simply click the "Learn More" button. This will provide you with comprehensive details about the trial, including objectives, procedures such as eye exams or retinal imaging, and eligibility criteria.
4. Complete the Health Profile: After clicking on the "Get started" button you will be taken to our efficient 5-step application process to provide important health information, including your diabetes history and any vision changes you've experienced. This helps us match you with the clinical trial that best fits your needs.
5. Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.